<bill session="116" type="s" number="2751" updated="2022-11-01T04:47:42Z">
  <state datetime="2019-10-30">REFERRED</state>
  <status>
    <introduced datetime="2019-10-30"/>
  </status>
  <introduced datetime="2019-10-30"/>
  <titles>
    <title type="display">Patient Access to ESRD New Innovative Devices Act</title>
    <title type="short" as="introduced">Patient Access to ESRD New Innovative Devices Act</title>
    <title type="official" as="introduced">A bill to amend title XVIII of the Social Security Act to improve access to innovative new medical devices furnished to individuals with end stage renal disease under part B of the Medicare program by establishing a new device add-on payment adjustment under such part.</title>
  </titles>
  <sponsor bioguide_id="C001056"/>
  <cosponsors>
    <cosponsor bioguide_id="C000174" joined="2020-01-13"/>
    <cosponsor bioguide_id="H001079" joined="2019-10-30"/>
    <cosponsor bioguide_id="J000300" joined="2019-10-30"/>
    <cosponsor bioguide_id="S001191" joined="2019-10-30"/>
  </cosponsors>
  <actions>
    <action datetime="2019-10-30">
      <text>Introduced in Senate</text>
    </action>
    <action datetime="2019-10-30" state="REFERRED">
      <text>Read twice and referred to the Committee on Finance.</text>
    </action>
  </actions>
  <committees>
    <committee code="SSFI" name="Senate Finance" subcommittee="" activity="Referral"/>
  </committees>
  <relatedbills>
    <bill session="116" type="h" number="2710" relation="unknown"/>
  </relatedbills>
  <subjects>
    <term name="Health"/>
    <term name="Administrative law and regulatory procedures"/>
    <term name="Department of Health and Human Services"/>
    <term name="Digestive and metabolic diseases"/>
    <term name="Drug safety, medical device, and laboratory regulation"/>
    <term name="Health care coverage and access"/>
    <term name="Health technology, devices, supplies"/>
    <term name="Medical tests and diagnostic methods"/>
    <term name="Medicare"/>
  </subjects>
  <amendments/>
  <summary date="2019-11-13T16:23:45Z" status="Introduced in Senate">Patient Access to ESRD New Innovative Devices Act

This bill requires the Centers for Medicare &amp; Medicaid Services (CMS) to establish a process to provide a certain payment adjustment under the Medicare end-stage renal disease (ESRD) prospective payment system. Specifically, the CMS must establish a process to provide for a temporary add-on payment adjustment for new medical devices used to diagnose, treat, or manage ESRD.</summary>
</bill>
